Trial
NCT02387216
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Elevation Oncology
Collaborators
Merrimack Pharmaceuticals
Condition
Non-Small Cell Lung Cancer
Intervention
MM-121
Why stopped
Based on the preliminary results seen during interim analysis, which were confirmed in the final analysis, the Sponsor terminated the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-12